Today

EU clears Suzano-Kimberly-Clark USD 3.4bn tissue joint venture

The European Commission has unconditionally approved the USD 3.4bn tissue and personal care joint venture between Suzano and Kimberly-Clark, covering international operations including the Kleenex brand. Suzano will hold 51% of the combined international tissue business. The deal, announced in June 2025, still awaits clearance from the UK competition authority.

Why this mattersClearance removes a major regulatory hurdle for one of the tissue sector's largest consolidation deals as producers seek scale amid overcapacity.

  • European Commission approved the joint venture unconditionally on 21 September 2026
  • Deal value stated at USD 3.4bn
  • Suzano will hold 51% of the combined international tissue business, including Kleenex
  • Transaction was first announced in June 2025
  • UK Competition and Markets Authority review is still pending
Suzano Kimberly-Clark counterparty
Relevant to you?

Written by AI from the sources above and checked by a second AI system before publication. No human wrote or edited this story. How it is made.